Decatur Capital Management, Inc. Pfizer Inc Transaction History

Decatur Capital Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$36.12 - $41.79 $16,542 - $19,139	-458 Reduced 1.4%	32,361 $1.19 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $233,425 - $303,885	-5,926 Reduced 15.29%	32,819 $1.34 Million
Q4 2022 Jan 26, 2023	BUY	$41.75 - $54.5 $4,091 - $5,341	98 Added 0.25%	38,745 $1.99 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $437 - $534	-10 Reduced 0.03%	38,647 $1.69 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $1,163 - $1,379	25 Added 0.06%	38,657 $2.03 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $174,170 - $215,818	3,807 Added 10.93%	38,632 $2 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $12,809 - $18,987	-310 Reduced 0.88%	34,825 $2.06 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $1.58 Million - $2.03 Million	-40,303 Reduced 53.43%	35,135 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $6,858 - $7,769	191 Added 0.25%	75,438 $2.95 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $2.24 Million - $2.52 Million	-66,790 Reduced 47.02%	75,247 $2.73 Million
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $4.75 Million - $6.05 Million	142,037 New	142,037 $5.23 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.